Latest News & Updates
Breaking News
22 hours ago
Vaibhavi M.
Other trending news you may like to read
Tonix Plans Adaptive Phase 2 Trial for Seasonal Lyme Disease Prevention Therapy, Advances Program Following FDA Type C Meeting
Tonix advances TNX-4800 following FDA feedback, supporting a Phase 2 study of its monoclonal antibody to prevent seasonal Lyme disease.
Vaibhavi M.
Medicus Pharma Appoints Dr. Faisal Mehmud as CEO of UK Subsidiary Antev, Strengthens Leadership to Advance Global Development of Teverelix®
Medicus Pharma appoints Dr. Faisal Mehmud as CEO of Antev to lead global development of Teverelix across multiple therapeutic indications.
Vaibhavi M.
Acurx Receives Positive FDA Feedback on Ibezapolstat Phase 3 Development Program, FDA Signals Potential Single-Trial NDA Pathway
Acurx receives positive FDA feedback on ibezapolstat's Phase 3 plan, supporting a potential single-trial NDA pathway for CDI treatment.
Vaibhavi M.
Decoy Therapeutics Expands Global Patent Portfolio for Antiviral Technology, Strengthens Intellectual Property Around D-MAV and IMP³ACT Platform
Decoy Therapeutics expands its patent portfolio with seven patent families covering its antiviral D-MAV technology and IMP³ACT design platform.
Vaibhavi M.
